1. Interactions betweenCYP11B2Promoter Methylation and Smoking Increase Risk of Essential Hypertension
    Tianlun Gu et al, 2016, BioMed Research International CrossRef
  2. Association of AGTR1 Promoter Methylation Levels with Essential Hypertension Risk: A Matched Case-Control Study
    Rui Fan et al, 2015, Cytogenetic and Genome Research CrossRef
  3. Hypermethylation of dihydrofolate reductase promoter increases the risk of hypertension in Chinese
    Zhishen Shen et al, 2020, Journal of Research in Medical Sciences CrossRef
  4. Role of COX-2 Promoter Methylation and Helicobacter pylori Infection in Impaired Gastric Ulcer Healing
    Hiroshi Yasuda et al, 2020, Chromatin and Epigenetics CrossRef
  5. MTHFD1 promoter hypermethylation increases the risk of hypertension
    Miao Xu et al, 2019, Clinical and Experimental Hypertension CrossRef
  6. Hypomethylation of the Toll-like receptor-2 gene increases the risk of essential hypertension
    Shuqi Mao et al, 2017, Molecular Medicine Reports CrossRef
  7. Radiation-induced cardiovascular disease: an overlooked role for DNA methylation?
    Magy Sallam et al, 2022, Epigenetics CrossRef
  8. Epigenetic Signatures in Hypertension
    Gerardo Alfonso Perez et al, 2023, Journal of Personalized Medicine CrossRef
  9. Functional relevance of promoter CpG island of human Angiotensin II type 1 receptor (AT1R) gene
    Mayank Chaudhary et al, 2019, Molecular and Cellular Biochemistry CrossRef
  10. Predicting High Blood Pressure Using DNA Methylome-Based Machine Learning Models
    Thi Mai Nguyen et al, 2022, Biomedicines CrossRef
  11. Association of GCK gene DNA methylation with the risk of clopidogrel resistance in acute coronary syndrome patients
    Jia Su et al, 2020, Journal of Clinical Laboratory Analysis CrossRef
  12. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995–2019)
    Ke Wang et al, 2022, Diabetes Research and Clinical Practice CrossRef
  13. Hypomethylation of the Interferon γ Gene as a Potential Risk Factor for Essential Hypertension: A Case-Control Study
    Xing-Jie Bao et al, 2018, The Tohoku Journal of Experimental Medicine CrossRef
  14. Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension
    Rui Fan et al, 2017, Molecular Medicine Reports CrossRef
  15. DNA methylation and hypertension: emerging evidence and challenges
    Liyuan Han et al, 2016, Briefings in Functional Genomics CrossRef
  16. The role of DNA methylation and histone modifications in blood pressure: a systematic review
    Valentina Gonzalez-Jaramillo et al, 2019, Journal of Human Hypertension CrossRef
  17. Novel methylation mark and essential hypertension
    Mayank Chaudhary, 2022, Journal of Genetic Engineering and Biotechnology CrossRef
  18. DNA methylation of hypertension-related genes and effect of riboflavin supplementation in adults stratified by genotype for the MTHFR C677T polymorphism
    Sophia D. Amenyah et al, 2021, International Journal of Cardiology CrossRef
  19. The epigenetics of aging
    Athanasios Metaxakis et al, 2023, Aging CrossRef
  20. CDKN2A and CDKN2B methylation in coronary heart disease cases and controls
    Jinyan Zhong et al, 2017, Experimental and Therapeutic Medicine CrossRef
  21. Epigenetic modification: a regulatory mechanism in essential hypertension
    Mohammed Arif et al, 2019, Hypertension Research CrossRef
  22. Unravelling the Lesser Known Facets of Angiotensin II Type 1 Receptor
    Mayank Chaudhary et al, 2017, Current Hypertension Reports CrossRef